Andrea Lindell Sells 1,347 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) Director Andrea Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Chemed Price Performance

Chemed stock opened at $421.37 on Friday. The company’s fifty day moving average price is $414.45 and its 200 day moving average price is $424.55. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $562.77. The stock has a market capitalization of $5.59 billion, a P/E ratio of 22.96, a P/E/G ratio of 1.63 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the company earned $5.63 EPS. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Maripau Wealth Management LLC raised its holdings in shares of Chemed by 5.4% during the 1st quarter. Maripau Wealth Management LLC now owns 970 shares of the company’s stock worth $366,000 after acquiring an additional 50 shares during the period. Segall Bryant & Hamill LLC purchased a new position in shares of Chemed during the 1st quarter worth $2,293,000. Cim LLC raised its holdings in shares of Chemed by 1.6% during the 1st quarter. Cim LLC now owns 2,325 shares of the company’s stock worth $878,000 after acquiring an additional 37 shares during the period. Amundi raised its holdings in shares of Chemed by 6,982.7% during the 1st quarter. Amundi now owns 35,555 shares of the company’s stock worth $13,431,000 after acquiring an additional 35,053 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after acquiring an additional 35 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CHE shares. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Monday. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Royal Bank Of Canada raised their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.